{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:28:07Z","timestamp":1770730087363,"version":"3.49.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100016122","name":"Fundaci\u00f3 Aut\u00f2noma Solid\u00e0ria","doi-asserted-by":"publisher","award":["FSXXXIV-03"],"award-info":[{"award-number":["FSXXXIV-03"]}],"id":[{"id":"10.13039\/501100016122","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AGAUR, Generalitat de Catalunya","award":["2017-SGR-1468"],"award-info":[{"award-number":["2017-SGR-1468"]}]},{"name":"Memorial Mercedes Llort Sender","award":["2025\/84\/09241941.1."],"award-info":[{"award-number":["2025\/84\/09241941.1."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04173-w","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:57:32Z","timestamp":1744361852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cognitive impairment and blood biomarkers of renal dysfunction in high-risk Nigerian population, with special attention to women and diabetes"],"prefix":"10.1186","volume":"25","author":[{"given":"Juan","family":"Fraile-Ramos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faeren","family":"Dogoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monday","family":"Ogiator","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efosa Kenneth","family":"Oghagbon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Gim\u00e9nez-Llort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"issue":"2","key":"4173_CR1","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet Public Health. 2022;7(2):e105\u201325.","journal-title":"Lancet Public Health"},{"key":"4173_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/195750","volume":"2014","author":"OO Olayinka","year":"2014","unstructured":"Olayinka OO, Mbuyi NN. Epidemiology of dementia among the elderly in Sub-Saharan Africa. Int J Alzheimers Dis. 2014;2014:1\u201315.","journal-title":"Int J Alzheimers Dis"},{"key":"4173_CR3","doi-asserted-by":"crossref","unstructured":"Adeloye D, Auta A, Ezejimofor M, Oyedokun A, Harhay MO, Rudan I et al. Prevalence of dementia in Nigeria: a systematic review of the evidence. J Glob Health Rep. 2019;3.","DOI":"10.29392\/joghr.3.e2019014"},{"issue":"6","key":"4173_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1080\/13607860600736182","volume":"10","author":"B Ochayi","year":"2006","unstructured":"Ochayi B, Thacher TD. Risk factors for dementia in central Nigeria. Aging Ment Health. 2006;10(6):616\u201320.","journal-title":"Aging Ment Health"},{"key":"4173_CR5","doi-asserted-by":"crossref","unstructured":"Nwinee VB, Ucheoma AC. Knowledge, attitude, and compliance with management of patients with selected risk; diabetes mellitus & hypertension on dementia. Selected primary health care centres in Nigeria: an impetus for primary prevention of vascular dementia. Alzheimer\u2019s Dementia 2023;19:S20.","DOI":"10.1002\/alz.079562"},{"issue":"1","key":"4173_CR6","first-page":"493","volume":"11","author":"EK Oghagbon","year":"2019","unstructured":"Oghagbon EK, Gim\u00e9nez-Llort L. Short height and poor education increase the risk of dementia in Nigerian type 2 diabetic women. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2019;11(1):493\u20139.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"4173_CR7","doi-asserted-by":"crossref","unstructured":"Nnamudi AC, Jerry Orhue NE, Ijeh II, Etim OE, Eke-Ogaranya IN, Obesity. Metabolic Abnormalities, Metabolic Syndrome and BMI-Metabolic-Risk Sub-Phenotypes among Young Adult Nigerians. Haya: The Saudi Journal of Life Sciences. 2020;5(6):90\u20137.","DOI":"10.36348\/sjls.2020.v05i06.001"},{"issue":"1","key":"4173_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/2251-6581-13-61","volume":"13","author":"SO Ogedengbe","year":"2014","unstructured":"Ogedengbe SO, Ezeani IU. Profile of metabolic abnormalities seen in patients with type 2 diabetes mellitus and their first degree relatives with metabolic syndrome seen in Benin City, Edo state Nigeria. J Diabetes Metab Disord. 2014;13(1):61.","journal-title":"J Diabetes Metab Disord"},{"key":"4173_CR9","unstructured":"Ijeh II, Okorie U, Ejike CE. Obesity, metabolic syndrome and BMI-metabolic-risk sub-phenotypes: A study of an adult Nigerian population. J Med Medical Sci 2010;1(6):254\u201360."},{"issue":"10","key":"4173_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591\u2013604.","journal-title":"Nat Rev Endocrinol"},{"key":"4173_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.arr.2016.09.007","volume":"34","author":"T Yang","year":"2017","unstructured":"Yang T, Sun Y, Lu Z, Leak RK, Zhang F. The impact of cerebrovascular aging on vascular cognitive impairment and dementia. Ageing Res Rev. 2017;34:15\u201329.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"4173_CR12","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3233\/JAD-2008-15110","volume":"15","author":"I Baldeiras","year":"2008","unstructured":"Baldeiras I, Santana I, Proen\u00e7a MT, Garrucho MH, Pascoal R, Rodrigues A, et al. Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2008;15(1):117\u201328.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"3","key":"4173_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/gps.3988","volume":"29","author":"S Karim","year":"2014","unstructured":"Karim S, Hopkins S, Purandare N, Crowther J, Morris J, Tyrrell P, et al. Peripheral inflammatory markers in amnestic mild cognitive impairment. Int J Geriatr Psychiatry. 2014;29(3):221\u20136.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"4173_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","volume":"117","author":"P Bermejo","year":"2008","unstructured":"Bermejo P, Mart\u00edn-Arag\u00f3n S, Bened\u00ed J, Sus\u00edn C, Felici E, Gil P, et al. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease. Immunol Lett. 2008;117(2):198\u2013202.","journal-title":"Immunol Lett"},{"issue":"6","key":"4173_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00592-020-01648-9","volume":"58","author":"Y You","year":"2021","unstructured":"You Y, Liu Z, Chen Y, Xu Y, Qin J, Guo S, et al. The prevalence of mild cognitive impairment in type 2 diabetes mellitus patients: a systematic review and meta-analysis. Acta Diabetol. 2021;58(6):671\u201385.","journal-title":"Acta Diabetol"},{"key":"4173_CR16","doi-asserted-by":"crossref","unstructured":"Li W, Sun L, Li G, Xiao S, Prevalence. Influence factors and cognitive characteristics of mild cognitive impairment in type 2 diabetes mellitus. Front Aging Neurosci. 2019;11.","DOI":"10.3389\/fnagi.2019.00180"},{"issue":"6","key":"4173_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.aogh.2015.12.012","volume":"81","author":"OA Fasanmade","year":"2016","unstructured":"Fasanmade OA, Dagogo-Jack S. Diabetes care in Nigeria. Ann Glob Health. 2016;81(6):821.","journal-title":"Ann Glob Health"},{"issue":"05","key":"4173_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.4236\/ojpm.2014.45035","volume":"04","author":"EK Oghagbon","year":"2014","unstructured":"Oghagbon EK, Gim\u00e9nez-Llort L. Sustaining increase in life expectancy in Africa requires active preventive measures against Non-Communicable diseases. Open J Prev Med. 2014;04(05):283\u201392.","journal-title":"Open J Prev Med"},{"key":"4173_CR19","doi-asserted-by":"crossref","unstructured":"Oghagbon E. Metabolic and clinical significance of diabetes mellitus type 2; implication for rising prevalence in Nigeria. J Biomed Res Clin Pract [Internet]. 2018;1(2):108\u201317. Available from: http:\/\/www.jbrcp.net","DOI":"10.46912\/1i2.201855"},{"issue":"2","key":"4173_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrendo.2010.228","volume":"7","author":"MWJ Strachan","year":"2011","unstructured":"Strachan MWJ, Reynolds RM, Marioni RE, Price JF. Cognitive function, dementia and type 2 diabetes mellitus in the elderly. Nat Rev Endocrinol. 2011;7(2):108\u201314.","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"4173_CR21","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1002\/alz.13359","volume":"19","author":"PB Adkins-Jackson","year":"2023","unstructured":"Adkins-Jackson PB, Kraal AZ, Hill\u2010Jarrett TG, George KM, Deters KD, Besser LM, et al. Riding the merry\u2010go\u2010round of Racial disparities in ADRD research. Alzheimer\u2019s Dement. 2023;19(10):4735\u201342.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"4173_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09540261.2022.2031915","volume":"34","author":"JM Castaldelli-Maia","year":"2022","unstructured":"Castaldelli-Maia JM, Bhugra D. What is geopsychiatry? Int Rev Psychiatry. 2022;34(1):1\u20132.","journal-title":"Int Rev Psychiatry"},{"issue":"3","key":"4173_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.diabres.2008.08.020","volume":"82","author":"SA Ebady","year":"2008","unstructured":"Ebady SA, Arami MA, Shafigh MH. Investigation on the relationship between diabetes mellitus type 2 and cognitive impairment. Diabetes Res Clin Pract. 2008;82(3):305\u20139.","journal-title":"Diabetes Res Clin Pract"},{"key":"4173_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/bs.pmbts.2019.01.004","volume":"162","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Zhao G, Yang N, Zhang L. Fasting blood glucose levels in patients with different types of diseases. Prog Mol Biol Transl Sci. 2019;162:277\u201392.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"7","key":"4173_CR25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1046\/j.1365-2389.2003.51313.x","volume":"51","author":"S Brescianini","year":"2003","unstructured":"Brescianini S, Maggi S, Farchi G, Mariotti S, Di Carlo A, Baldereschi M, et al. Low total cholesterol and increased risk of dying: are low levels clinical warning signs in the elderly?? Results from the Italian longitudinal study on aging. J Am Geriatr Soc. 2003;51(7):991\u20136.","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"4173_CR26","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.2337\/db14-1603","volume":"64","author":"CL Haase","year":"2015","unstructured":"Haase CL, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R. HDL cholesterol and risk of type 2 diabetes: A Mendelian randomization study. Diabetes. 2015;64(9):3328\u201333.","journal-title":"Diabetes"},{"issue":"8","key":"4173_CR27","doi-asserted-by":"publisher","first-page":"E1352","DOI":"10.1210\/jc.2013-1680","volume":"98","author":"A Abbasi","year":"2013","unstructured":"Abbasi A, Corpeleijn E, Gansevoort RT, Gans ROB, Hillege HL, Stolk RP, et al. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. J Clin Endocrinol Metab. 2013;98(8):E1352\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4173_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1758-5996-4-12","volume":"4","author":"EP de Oliveira","year":"2012","unstructured":"de Oliveira EP, Burini RC. High plasma uric acid concentration: causes and consequences. Diabetol Metab Syndr. 2012;4(1):12.","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"4173_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/brain\/awn316","volume":"132","author":"SM Euser","year":"2008","unstructured":"Euser SM, Hofman A, Westendorp RGJ, Breteler MMB. Serum uric acid and cognitive function and dementia. Brain. 2008;132(2):377\u201382.","journal-title":"Brain"},{"key":"4173_CR30","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2147\/NDT.S145812","volume":"13","author":"L Xue","year":"2017","unstructured":"Xue L, Liu Y, Xue H, Xue J, Sun K, Wu L, et al. Low uric acid is a risk factor in mild cognitive impairment. Neuropsychiatr Dis Treat. 2017;13:2363\u20137.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4173_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.exger.2014.10.013","volume":"60","author":"TD Vannorsdall","year":"2014","unstructured":"Vannorsdall TD, Kueider AM, Carlson MC, Schretlen DJ. Higher baseline serum uric acid is associated with poorer cognition but not rates of cognitive decline in women. Exp Gerontol. 2014;60:136\u20139.","journal-title":"Exp Gerontol"},{"issue":"3","key":"4173_CR32","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1159\/000454660","volume":"6","author":"K Suzuki","year":"2016","unstructured":"Suzuki K, Koide D, Fujii K, Yamazaki T, Tsuji S, Iwata A. Elevated serum uric acid levels are related to cognitive deterioration in an elderly Japanese population. Dement Geriatr Cogn Dis Extra. 2016;6(3):580\u20138.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"4173_CR33","doi-asserted-by":"crossref","unstructured":"Tian T, Liu X, run, Li T ting, Nie Z, chao, Li Sjing, Tang Y et al. Detrimental effects of long-term elevated serum uric acid on cognitive function in rats. Sci Rep. 2021;11(1):6732.","DOI":"10.1038\/s41598-021-86279-y"},{"issue":"1","key":"4173_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1159\/000329097","volume":"34","author":"B Afsar","year":"2011","unstructured":"Afsar B, Elsurer R, Covic A, Johnson RJ, Kanbay M. Relationship between uric acid and subtle cognitive dysfunction in chronic kidney disease. Am J Nephrol. 2011;34(1):49\u201354.","journal-title":"Am J Nephrol"},{"key":"4173_CR35","doi-asserted-by":"crossref","unstructured":"Mijailovic NR, Vesic K, Borovcanin MM. The influence of serum uric acid on the brain and cognitive dysfunction. Front Psychiatry. 2022;13.","DOI":"10.3389\/fpsyt.2022.828476"},{"key":"4173_CR36","doi-asserted-by":"crossref","unstructured":"Harman D. The aging process. Proceedings of the National Academy of Sciences. 1981;78(11):7124\u20138.","DOI":"10.1073\/pnas.78.11.7124"},{"issue":"1","key":"4173_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/bmb\/ldp033","volume":"92","author":"IJ Deary","year":"2009","unstructured":"Deary IJ, Corley J, Gow AJ, Harris SE, Houlihan LM, Marioni RE, et al. Age-associated cognitive decline. Br Med Bull. 2009;92(1):135\u201352.","journal-title":"Br Med Bull"},{"key":"4173_CR38","unstructured":"Moran C, Beare R, Wang W, Callisaya M, Srikanth V, Weiner M et al. Type 2 diabetes mellitus, brain atrophy, and cognitive decline. Neurology. 2019;92(8)."},{"issue":"1","key":"4173_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11357-016-9871-8","volume":"38","author":"AA Khan","year":"2016","unstructured":"Khan AA, Quinn TJ, Hewitt J, Fan Y, Dawson J. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Omaha). 2016;38(1):16.","journal-title":"Age (Omaha)"},{"issue":"8","key":"4173_CR40","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/nu10080975","volume":"10","author":"C Tana","year":"2018","unstructured":"Tana C, Ticinesi A, Prati B, Nouvenne A, Meschi T. Uric acid and cognitive function in older individuals. Nutrients. 2018;10(8):975.","journal-title":"Nutrients"},{"key":"4173_CR41","doi-asserted-by":"crossref","unstructured":"Zhang J, Tang L, Hu J, Wang Y, Xu Y. Uric acid is associated with cognitive impairment in the elderly patients receiving maintenance hemodialysis\u2014A two-center study. Brain Behav. 2020;10(3).","DOI":"10.1002\/brb3.1542"},{"issue":"1\u20132","key":"4173_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jns.2010.07.007","volume":"297","author":"SH Heo","year":"2010","unstructured":"Heo SH, Lee SH. High levels of serum uric acid are associated with silent brain infarction. J Neurol Sci. 2010;297(1\u20132):6\u201310.","journal-title":"J Neurol Sci"},{"issue":"3","key":"4173_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.kint.2017.08.033","volume":"93","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Li T, Xian H, Yan Y, Al-Aly Z. Higher blood Urea nitrogen is associated with increased risk of incident diabetes mellitus. Kidney Int. 2018;93(3):741\u201352.","journal-title":"Kidney Int"},{"issue":"1","key":"4173_CR44","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1309\/LM920SBNZPJRJGUT","volume":"45","author":"JH Salazar","year":"2014","unstructured":"Salazar JH. Overview of Urea and creatinine. Lab Med. 2014;45(1):e19\u201320.","journal-title":"Lab Med"},{"issue":"1","key":"4173_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.31254\/jmr.2016.2104","volume":"2","author":"S Bamanikar","year":"2016","unstructured":"Bamanikar S, Bamanikar A, Arora A. Study of serum Urea and creatinine in diabetic and non-diabetic patients in in a tertiary teaching hospital. J Med Res. 2016;2(1):12\u20135.","journal-title":"J Med Res"},{"key":"4173_CR46","doi-asserted-by":"crossref","unstructured":"Philbert SA, Xu J, Scholefield M, Patassini S, Church SJ, Unwin RD et al. Extensive multiregional Urea elevations in a case-control study of vascular dementia point toward a novel shared mechanism of disease amongst the age-related dementias. Front Mol Neurosci. 2023;16.","DOI":"10.3389\/fnmol.2023.1215637"},{"key":"4173_CR47","doi-asserted-by":"crossref","unstructured":"Scholefield M, Church SJ, Xu J, Patassini S, Roncaroli F, Hooper NM et al. Severe and regionally widespread increases in tissue Urea in the human brain represent a novel finding of pathogenic potential in Parkinson\u2019s disease dementia. Front Mol Neurosci. 2021;14.","DOI":"10.3389\/fnmol.2021.711396"},{"key":"4173_CR48","unstructured":"Vijayakumar TM, Shirisha GBN, Farzana Begam MD, Dhanaraju MD. Mechanism Linking Cognitive Impairment and Diabetes mellitus Magharla Dasaratha Dhanaraju giet school of pharmacy. European Journal of Applied Sciences [Internet]. 2012;4(1). Available from: https:\/\/www.researchgate.net\/publication\/231537655"},{"issue":"1","key":"4173_CR49","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijdm.2011.01.001","volume":"3","author":"MAH Hazari","year":"2015","unstructured":"Hazari MAH, Ram Reddy B, Uzma N, Santhosh Kumar B. Cognitive impairment in type 2 diabetes mellitus. Int J Diabetes Mellit. 2015;3(1):19\u201324.","journal-title":"Int J Diabetes Mellit"},{"issue":"9","key":"4173_CR50","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrgastro.2013.99","volume":"10","author":"RF Butterworth","year":"2013","unstructured":"Butterworth RF. The liver\u2013brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol. 2013;10(9):522\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04173-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04173-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T08:57:40Z","timestamp":1744361860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04173-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4173"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04173-w","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yes, the study was approved by the Ethics committee of the Benue State University Teaching Hospital, Makurdi, Nigeria. It adhered to the ethical principles for medical research involving human participants of the declaration of Helsinki. All the participants provided signed and written informed consent. Subjects who were illiterate had study plans interpreted in their local languages (Tiv, Idoma, Igede, Hausa) before their signed consent was taken and included in the study. The anonymity of participants was guaranteed, and the statistical analysis was performed by a researcher blind to the experiment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}